Ischemic acute renal failure is characterized by damages to the proximal straight tubule in the outer medulla. Lesions include loss of polarity, shedding into the tubule lumen, and eventually necrotic or apoptotic death of epithelial cells. It was recently shown that peroxisome proliferator-activated receptor ␤/␦ (PPAR␤/␦) increases keratinocyte survival after an inflammatory reaction. Therefore, whether PPAR␤/␦ could contribute also to the control of tubular epithelium death after renal ischemia/ reperfusion was tested. It was found that PPAR␤/␦ ؉/؊ and PPAR␤/␦ ؊/؊ mutant mice exhibited much greater kidney dysfunction and injury than wild-type counterparts after a 30-min renal ischemia followed by a 36-h reperfusion. Conversely, wild-type mice that were given the specific PPAR␤/␦ ligand L-165041 before renal ischemia were completely protected against renal dysfunction, as indicated by the lack of rise in serum creatinine and fractional excretion of Na T he proximal straight tubule in the outer medulla of the kidney is particularly susceptible to ischemia/reperfusion injury, which remains the leading cause of acute renal failure (1,2). Damages to this segment are characterized initially by the disruption of tight junctions that control both paracellular permeability and cell polarity (3,4). The loss of cell polarity is responsible for the redistribution of integrin subunits from the basolateral to the apical membrane, contributing to the shedding of cells into the tubule lumen (4). Both increase in paracellular permeability and desquamation lead to back-leakage of glomerular filtrate (5). With more sustained ischemia/reperfusion, epithelial cells of the proximal tubule undergo necrotic or apoptotic cell death (6). Epithelial cells that do not die participate in the regeneration of tubular epithelium and the restoration of renal function (2,7). They use integrins to flatten, spread, and migrate into areas denuded by exfoliation, where they dedifferentiate, proliferate, and differentiate again (8).
T he proximal straight tubule in the outer medulla of the kidney is particularly susceptible to ischemia/reperfusion injury, which remains the leading cause of acute renal failure (1, 2) . Damages to this segment are characterized initially by the disruption of tight junctions that control both paracellular permeability and cell polarity (3, 4) . The loss of cell polarity is responsible for the redistribution of integrin subunits from the basolateral to the apical membrane, contributing to the shedding of cells into the tubule lumen (4) . Both increase in paracellular permeability and desquamation lead to back-leakage of glomerular filtrate (5) . With more sustained ischemia/reperfusion, epithelial cells of the proximal tubule undergo necrotic or apoptotic cell death (6) . Epithelial cells that do not die participate in the regeneration of tubular epithelium and the restoration of renal function (2, 7) . They use integrins to flatten, spread, and migrate into areas denuded by exfoliation, where they dedifferentiate, proliferate, and differentiate again (8) .
Peroxisome proliferator-activated receptor ␤/␦ (PPAR␤/␦; called PPAR␤ hereafter) is a ligand-activated transcription factor that belongs to the nuclear hormone receptor family (9) . It plays a key role in cell survival (10 -14) . For example, PPAR␤ activation leads to the expression of genes that increase the resistance of keratinocytes to apoptotic death (11, 13) . In these cells, PPAR␤ expression is also involved in the control of cell adhesion to the extracellular matrix and migration (10) . All of these properties may account for the finding that PPAR␤ expression and activation participate in skin wound repair (10) .
By contrast with PPAR␣ and PPAR␥, PPAR␤ is ubiquitously expressed in all nephron segments within the kidney. In particular, it is the predominant PPAR isotype in the proximal straight tubule (15) . Because of this high expression, we assessed whether PPAR␤ would contribute to the survival of proximal tubular cells in a model of ischemic acute renal failure. We found that PPAR␤-deficient mice were remarkably susceptible to renal ischemia/reperfusion injury. Conversely, mice that were given PPAR␤ ligand pretreatment were completely protected. To identify a possible mechanism involved in this protection, we performed in vitro experiments that emphasized the critical role of both antiapoptotic Akt signaling pathway and cell spreading. These results provide proof that PPAR␤ is a promising pharmacologic target for preconditioning strategy in ischemic acute renal failure.
Materials and Methods

Cell Cultures
Human proximal tubular epithelial cells (HK-2 cell line; American Type Culture Collection, Manassas, VA) were cultured at 37°C in a serum-free keratinocyte-SFM medium supplemented with human recombinant EGF and pituitary bovine extract (Life Technologies, Cergy Pontoise, France), under a 5% CO 2 and 95% air atmosphere. These cells were exposed to specific PPAR␤ agonists, including carbaprostacyclin (Biomol, Plymouth Meeting, PA) and L-165041 (provided by the Laboratoires Merck Sharp & Dohme-Chibret, Paris, France). Cell viability and cell proliferation were assessed by measuring the exclusion of trypan blue and the uptake of [ 3 H]thymidine, respectively (16) . 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (Oncogene, La Jolla, CA) was used as Akt inhibitor.
Immunofluorescence Microscopy and Western Blot Analysis
HK-2 cells were grown on multiwell slides and exposed for 24 h to PPAR␤ ligands or vehicle alone. Immunofluorescence staining of actin cytoskeleton and focal adhesion plaques was performed on cells that were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100, using both the actin cytoskeleton and focal adhesion staining kit (Chemicon International, Temecula, CA). Confocal microscopy was performed using a Leica TCS laser scanning confocal microscope (Lasertechnik, GmbH, Wetzlar, Germany).
For Western blot analysis, cell lysates were prepared by scraping cells into an ice-cold protease inhibitory buffer. Proteins were separated by electrophoresis on a 7.5% polyacrylamide-SDS gel and transferred onto a nitrocellulose membrane (Immobilon-P; Millipore, Bedford, MA) before detection of PPAR␤ with the specific primary anti-PPAR␤ polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA; dilution 1:1000) and a peroxidase-labeled anti-IgG secondary antibody (1:10,000 dilution). Thereafter, the membrane was developed with the ECL detection reagent (Amersham Pharmacia Biotech, Saclay, France).
Assessment of Apoptosis
Apoptosis of HK-2 cells that were exposed for 24 h to 0.5 mM H 2 O 2 was determined by using either the annexin V-FITC detection kit (Sigma-Aldrich, St. Louis, MO) to detect externalized phosphatidylserine or the caspase 3 activity detection kit (Oncogene Research Products, Merck Biosciences, Nottingham, UK). The antiapoptotic role of PPAR␤ via the Akt1 signaling cascade was assessed by measuring Akt1 phosphorylation with the Fast Activated Cell-based ELISA Kit (Active motif, Rixensart, Belgium) according to the manufacturer's instructions and by analyzing the effect of Akt1 inhibitor (Calbiochem, San Diego, CA) on L-165041 antiapoptotic efficiency.
Animals
Male C57BL/6 mice that weighed 20 to 25 g were used for pharmacologic approaches. They were given L-165041 (30 mg/kg per d) or vehicle alone (0.5% carboxymethylcellulose) by gavage for 2 d before the induction of acute renal failure and during the reperfusion period. These doses of L-165041 are sufficient to produce the activation of PPAR ␤ but not PPAR␣ and PPAR␥ (17, 18) . Male PPAR␤-deficient mice (11) and C57BL/6 ϫ 129/SV wild-type control mice that weighed 20 to 25 g were used for genetic approaches.
Induction of Ischemic Acute Renal Failure
The studies were conducted by following established guidelines for animal care, and all protocols were approved by the INSERM and by the Service Vétérinaire Cantonal of Lausanne. For pharmacologic approaches, C57BL/6 mice were anesthetized by intraperitoneal administration of Avertin (Sigma-Aldrich) and subjected to bilateral flank incisions as described previously (19) . Both renal pedicles were crossclamped for 30 min. This time was chosen to obtain a reproducible acute renal failure while minimizing animal mortality. After clamp removal, the kidneys were inspected for restoration of blood flow, the surgical wounds were sutured, and animals were allowed to recover. Finally, to maintain fluid balance and volume status, mice were given 0.3 ml of warm saline intraperitoneally. After 36 h of reperfusion, they were re-anesthetized, blood and urine samples were collected, and kidneys were removed for morphologic analyses. For genetic approaches, wild-type and mutant C57BL/6 ϫ 129/SV had identical surgical procedures except that they were anesthetized with xylazine (10 mg/kg) and ketamine (75 mg/kg).
Assessment of Renal Function
Samples of serum and urine were collected from all mice, and creatinine and Na ϩ levels were measured using an autoanalyzer. The fractional excretion of Na ϩ was calculated as the ratio of Na ϩ clearance to creatinine clearance.
Evaluation of Renal Histology
Kidneys were fixed in 4% paraformaldehyde and processed for paraffin embedding. Sections of 3-m thickness were made and stained with the periodic acid-Schiff (PAS) reagent. Tubular injury was scored by estimating the percentage of tubules in the cortex or the outer medulla that showed epithelial necrosis or had luminal necrotic debris and tubular dilation, as follows: 0, none; 1, Ͻ5%; 2, 5 to 25%; 3, 25 to 75%; and 4, Ͼ75% (20) . All evaluations were made on 10 fields per section and 10 sections per kidney, by two different blinded observers. In addition, tubular dilation, a hallmark of renal ischemia/reperfusion injury (1), was assessed by quantitative morphometric analysis, with the use of an automated image analyzing system. Measurements were performed on randomly selected sections that were stained with hematoxylin and eosin (five per kidney). The lumen area of cortical tubules was measured at ϫ40 magnification from digital images (Nikon Eclipse 800 light microscope and DXM 1200 digital camera; Nikon, Champigny sur Marne, France) and image analysis software (Image J 1.33; http://rsb.info.nih.gov/ij/download/). Results were expressed as the surface occupied by tubular lumens relative to the total cortical area.
Separate 3-m sections were stained with transferase-mediated dUTP nick-end labeling (TUNEL) reagent (Promega, Madison, WI) and propidium iodide for apoptosis detection according to the manufacturer's instructions. The number of TUNEL-positive nuclei per field was evaluated in five fields per section and five sections per kidney.
Detection of Neutrophils and Macrophages Using Myeloperoxidase Assay
Snap-frozen kidney samples were thawed, added to ice-cold 50 mM PBS (pH 6.0) supplemented with 0.5% hexadecyltrimethylammonium bromide up to concentrations of 0.1 g renal tissue/ml, and homogenized with 20 strokes in a glass homogenizer. The lysates then were freeze-thawed three times and centrifuged at 20,000 ϫ g for 1 h at 4°C. Supernatants were assayed for myeloperoxidase (MPO), as described previously (21) . Results were expressed as OD/min per mg wet tissue.
Statistical Analyses
Results are expressed as mean Ϯ SEM. Comparisons between groups of values were made with the t test for unrelated groups. A difference between groups of P Ͻ 0.05 was considered significant. (Figure 1 ). This renal dysfunction was corroborated by the occurrence of increased histologic damage in the cortex and the outer medulla in mutant mice as compared with wild-type counterparts ( Figure 2 
Results
PPAR␤
PPAR␤ Ligands Modulated the Phenotype of Proximal Tubular Cells
Defects in epithelial cells of the proximal straight tubule are the histologic hallmark of renal ischemia/reperfusion injury. Main alterations are the disruption of the epithelial cell cytoskeleton, loss of cell polarity, and ultimately cell death. Thus, we examined these cytopathologic events using the human proximal tubular cell line HK-2 as an experimental tool. These cells showed abundant expression of PPAR␤, the level of which was not modified by PPAR␤ ligands, including carbaprostacyclin (data not shown) and L-165041 ( Figure 3A ). In the absence of treatment, HK-2 cells displayed a rounded shape with few cellular extensions ( Figure 3B ). Actin fibers were sparse, distributed mainly at the cell periphery, and focal adhesion plaques with vinculin were condensed. Exposure of these cells to the PPAR␤ ligand carbaprostacyclin (data not shown) or L-165041 ( Figure 3B ) for 24 h resulted in a marked alteration of this morphology. Cells became flattened and spread, concomitant with the coalescence of actin fibers into stress fibers. In addition, the focal adhesion component vinculin was now scattered throughout the basal cell membrane, in close contact with actin fibers. These results dramatically emphasized the role of PPAR␤ in the structural organization of the epithelial cytoskeleton, which, in turn, is responsible for cell spreading and adherence to extracellular matrix.
PPAR␤ Ligands Modulated the Viability of Proximal Tubular Cells
We then analyzed the impact of the PPAR␤ ligand on HK-2 cell survival. Twenty-four-hour exposure to effective concentrations of L-165041 did not affect growth and viability of these cells ( Figure 4A ). Because oxygen-derived free radicals are known to dramatically reduce epithelial survival in ischemic acute renal failure (22), we analyzed the impact of the PPAR␤ ligand on cell survival during oxidative stress. Apoptosis, which was minimal in control cells, reached 29.9 Ϯ 5.6% in cells that were exposed for 24 h to 0.5 mM H 2 O 2 ( Figure 4B ). This Figure 1 . PPAR␤ ϩ/Ϫ and PPAR␤ Ϫ/Ϫ mice developed more severe ischemic acute renal failure than wild-type mice. Mice were subjected to 30 min of renal ischemia followed by 36 h of reperfusion. Renal dysfunction was reflected by increases in serum creatinine levels. *P Ͻ 0.05 versus wild-type mice. mice, albeit not reaching statistical significance. Magnification, ϫ200 in A; ϫ400 in A inset.
death response was dramatically decreased in a dose-dependent manner in cells that were pretreated with L-165041. Prominent among the signaling pathways involved in the resistance to apoptosis is the ubiquitous phosphatidylinositol-3-kinase/Akt1 signaling pathway (23) . L-165041 dosedependently increased active phosphorylated Akt1 levels without modifying total Akt1 expression ( Figure 5A ). Remarkably, a specific Akt1 inhibitor prevented the antiapoptotic effect of L-165041 completely ( Figure 5B ). These results demonstrate that activated PPAR␤ exhibits a major antiapoptotic effect on HK-2 cells exposed to oxidative stress, via activation of the phosphatidylinositol-3-kinase/Akt1 signaling pathway.
Wild-Type Mice Given L-165041 Pretreatment Developed Less Severe Ischemic Acute Renal Failure
Acute renal failure occurs mainly in the context of various functional alterations of several organs. Although it severely aggravates the vital prognosis, the damage caused is reversible in case of survival, the epithelium being healed via mechanisms that include induction of heat-shock proteins and production of growth factors that induce tubular regeneration (1,2). These processes have been proposed as targets for preconditioning treatments that would protect the kidney in situations of imminent ischemic renal failure. The renal prejudice observed in PPAR␤ mutant mice, together with the demonstration of the important action of PPAR␤ on cell morphology and protection against apoptosis, identifies PPAR␤ as a putative target for preconditioning treatments. To test this hypothesis, we pretreated a group of C57BL/6 mice with L-165041 (30 mg/kg per d for 2 d before and during the reperfusion period). This treatment completely prevented the ischemia/reperfusion-de- pendent rise in serum creatinine and fractional excretion of Na ϩ , which are markers of glomerular and tubular dysfunction, respectively ( Figure 6 ). Remarkably, this dysfunction abrogation was associated with a significant reduction in tubular injury (including necrosis and sloughing of epithelial cells) in the cortex and the outer medulla as assessed by semiquantitative analysis ( Figure 7 ) and with a significant decrease in dilation of the cortical tubules as assessed by quantitative morphometric analysis (wild-type mice 0.123 Ϯ 0.025; wild-type mice given L-165041 0.064 Ϯ 0.010; P Ͻ 0.05). Furthermore, there was a reduction in monocytes/macrophages and neutrophils influx, as reflected by the decrease in MPO activity (Figure 8 ). The PPAR␤ ligand also had a major effect on the occurrence of apoptosis. Kidneys from mice that were subjected to ischemic acute renal failure showed extensive TUNEL-positive staining, predominantly in the tubules of the outer medulla, in sharp contrast with mice that were pretreated with L-165041 before the induction of the failure (Figure 9 ). These results demonstrate a very strong protective role of PPAR␤, which designates it as a very promising pharmacologic target for preconditioning strategies in ischemic acute renal failure.
Discussion
This study identifies PPAR␤ as a newly recognized participant in the control of renal ischemia reperfusion injury. We found that PPAR␤ ϩ/Ϫ and PPAR␤ Ϫ/Ϫ mice had a much worse kidney dysfunction than PPAR␤ ϩ/ϩ mice. Conversely, wildtype mice that were pretreated with L-165041 were functionally and histologically protected against ischemic acute renal failure. Although the mechanisms underlying this protection are conceivably numerous, our results suggest that PPAR␤ expression and activation are required mainly to limit epithelial cell death in the proximal straight tubule. Various reports have shown previously that PPAR␤ activation protects cells against apoptosis. Colon carcinoma cells that are exposed to PPAR␤ ligand become resistant to growth factor withdrawal-induced apoptosis (14) . Keratinocytes that are exposed to proinflammatory cytokines TNF-␣ and IFN-␥ express high levels of PPAR␤ and produce endogenous PPAR␤ ligands, which increase the resistance of these cells to TNF-␣-induced apoptosis (11) . Within the kidney, medullary interstitial cells that are exposed to hypertonic stress produce PGI 2 , which, in turn, increases their survival through a PPAR␤-mediated process (12) . In the present study, we extended the list of PPAR␤ target cells by demonstrating the antiapoptotic role of PPAR␤ ligand in HK-2 cells that were exposed to oxidative stress. The apoptotic process in these human proximal tubular cells, which are known to be much more sensitive to oxidative stress than distal tubular cells (22) , results from an increase in the activity of extracellular signal-regulated kinase-1 and-2 and a decrease in phosphorylated Akt (24) . We have demonstrated the importance of Akt phosphorylation in the antiapoptotic role of PPAR␤. These results are consistent with our previous demonstration of Akt1 participation in the molecular mechanism by which PPAR␤ protects keratinocytes against apoptosis (13) .
The apoptotic process in HK-2 cells may also result from their limited interaction with the extracellular matrix (anoikis) (7) . In this study, we demonstrated for the first time that PPAR␤ activation increases cell spreading, raising the possibility that increased cell interaction with the extracellular matrix may play a part in PPAR␤-induced resistance to apoptosis. Most important, PPAR␤-induced cell flattening and spreading are potentially important in vivo during ischemic acute renal failure for preventing back-leakage of the glomerular filtrate (5) . Although the molecular mechanisms involved in this process remain to be characterized, the role of Akt is suggested by the recent observation that Akt signaling pathway promotes integrin recycling and cell spreading (25) .
Apoptotic cell death contributes in part to the inflammatory response observed after renal ischemia/reperfusion (26) . Thus, the anti-inflammatory effect of PPAR␤ ligands in our model, as demonstrated by a decrease in MPO activity, could be related to the PPAR␤-dependent abrogation of epithelial cell apoptosis. Alternatively, PPAR␤ ligands could trigger directly inflammatory and/or endothelial cells. Along with this hypothesis, spe- cific PPAR␤ ligands have been shown to inhibit the expression of proinflammatory cytokines (e.g., monocyte chemoattractant protein-1) in both macrophages and endothelial cells (27, 28) . Because vascular endothelium activation and injury contribute to reduce renal perfusion and, hence, to decrease GFR (29, 30) , PPAR␤ ligands would protect renal function by preventing these mechanisms as well.
Apart from PPAR␤, the other PPAR isotypes may affect tubular cell apoptosis and, thereby, renal ischemia/reperfusion lesions. PPAR␥ is expressed mainly in the inner medullary collecting duct and to a lesser extent in the proximal tubule (15, 31) . Administration of rosiglitazone and ciglitazone, two specific PPAR␥ agonists, have been shown to reduce renal dysfunction and injury associated with ischemia/reperfusion of the rat kidney (32) . However, in sharp contrast to these in vivo experiments, PPAR␥ ligands have been shown to stimulate rather than prevent proximal tubular cell apoptosis in vitro, as did overexpression of PPAR␥ (31, 33) . PPAR␣ is also expressed in the convoluted part of the proximal tubule (15) . Because ischemic lesions affect predominantly the straight part of proximal tubule (S3), the mechanism by which PPAR␣ agonists exert beneficial effects in experimental models of ischemic acute renal failure (34, 35) remains to be elucidated.
In summary, our data demonstrate that PPAR␤ activation has highly beneficial effects in ischemic acute renal failure, as a result of its combined action on cell survival and cytoskeleton reorganization. Importantly, a short preconditioning strategy with PPAR␤ agonists was highly protective. Thus, PPAR␤ agonists should be considered seriously as a novel means of conferring renal protection in clinical situations that carry a high risk for ischemic renal failure occurrence. New strategies of preconditioning or prevention are indeed badly needed for this syndrome, which still has a mortality of Ͼ50%.
